Exodus Point Capital Management, LP Bristol Myers Squibb CO Transaction History

Exodus Point Capital Management, LP

$14.7 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $9.48 Million - $10.6 Million	-163,721 Reduced 73.71%	58,397 $3.39 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $24.3 Million - $27 Million	-381,907 Reduced 63.23%	222,118 $14.2 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $24.8 Million - $28.1 Million	377,684 Added 166.87%	604,025 $41.9 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $15.5 Million - $18.4 Million	226,341 New	226,341 $16.3 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $12.6 Million - $14.6 Million	-234,125 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $11.8 Million - $13.8 Million	199,709 Added 580.28%	234,125 $13.9 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $161,832 - $176,235	2,614 Added 8.22%	34,416 $2.3 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2.24 Million - $2.52 Million	-37,719 Reduced 54.26%	31,802 $2.01 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $4.01 Million - $4.55 Million	69,521 New	69,521 $4.31 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $16 Million - $17.7 Million	-278,398 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $9.42 Million - $11 Million	171,879 Added 161.36%	278,398 $16.4 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $4.94 Million - $7.18 Million	106,519 New	106,519 $5.94 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $3.03 Million - $3.95 Million	-61,528 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $588,771 - $698,073	-13,766 Reduced 18.28%	61,528 $3.12 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $3.09 Million - $3.69 Million	68,562 Added 1018.45%	75,294 $3.59 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $328,252 - $425,664	6,732 New	6,732 $350,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account